当前位置: 首页 > 期刊点评 > 搜索结果
以下为"DRUG TESTING AND ANALYSIS"的结果:
DRUG TESTING AND ANALYSIS
基本信息
曾用刊名:DRUG TESTING AND ANALYSIS
主办单位:
出版周期:
ISSN:
CN:
出版地:
展开
出版信息
专辑名称:
专题名称:
评价信息
该刊被以下数据库收录:

提示:

1、投稿方式:在线投稿。

2、期刊网址:

https://analyticalsciencejournals.onlinelibrary.wiley.com/journal/19427611

3、投稿网址:https://mc.manuscriptcentral.com/dta

4、官网邮箱:m.thevis@biochem.dshs-koeln.de(主编)

(更多编辑邮箱请查看期刊官网信息)

5、期刊刊期:月刊,一年出版12期。

2021年11月1日星期一

                          

 

投稿须知【官网信息】

 

Author Guidelines

General

Drug Testing and Analysis (DTA) is devoted to the publication of papers dealing with the development and application of techniques for the determination of controlled or controversial substances.

Papers must clearly be of scientific value in the field and will be submitted to two independent referees. Contributions must be in English and must not have been published elsewhere, and authors must agree not to communicate the same material for publication to any other journal. It is in the author's interest to ensure accurate and consistent presentation and thus avoid publication delays. There are no page charges.

The Editors are aware that restrictions may be enforced by certain agencies concerning the provision of comprehensive synthesis methods for controversial substances. Articles without comprehensive synthesis methodologies may be considered at the discretion of the Editor providing the scientific integrity of the article is not compromised. If affected, authors should state explicitly the reason for the omission in their covering letter together with a statement justifying the omission in the submitted article.

Data Protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

Expects Data Sharing

DTA encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

Visit re3data.org or fairsharing.org to help identify registered and certified data repositories relevant to your subject area.

More information about the Data Sharing Policy can be found here.

Manuscript Submission

All papers must be submitted via the online system. Drug Testing and Analysis operates an online submission and peer review system that allows authors to submit articles online and track their progress via a web interface. Please read the remainder of these instructions to authors and then click http://mc.manuscriptcentral.com/dta to navigate to the Drug Testing and Analysis online submission site.

IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have created an account.

File types. Preferred formats for the text and tables of your manuscript are .docx, .doc, .rtf, .ppt, .xls. LaTeX files may be submitted provided that an .eps or .pdf file is provided in addition to the source files. Figures may be provided in .tiff or .eps format.

INITIAL SUBMISSION

NON-LATEX USERS: Editable source files must be uploaded at this stage. Tables must be on separate pages after the reference list, and not be incorporated into the main text. Figures should be uploaded as separate figure files.

LATEX USERS: For reviewing purposes you should upload a single .pdf that you have generated from your source files. You must use the File Designation "Main Document" from the dropdown box.

REVISION SUBMISSION

NON-LATEX USERS: Editable source files must be uploaded at this stage. Tables must be on separate pages after the reference list, and not be incorporated into the main text. Figures should be uploaded as separate figure files.

LATEX USERS: When submitting your revision you must still upload a single .pdf that you have generated from your now revised source files. You must use the File Designation "Main Document" from the dropdown box. In addition you must upload your TeX source files. For all your source files you must use the File Designation "Supplemental Material not for review". Previous versions of uploaded documents must be deleted. If your manuscript is accepted for publication we will use the files you upload to typeset your article within a totally digital workflow.

Accepted Articles

'Accepted Articles' have been accepted for publication and undergone full peer review but have not been through the copyediting, typesetting, pagination and proofreading process. Accepted Articles are published online a few days after final acceptance, appear in PDF format only (without the accompanying full-text HTML) and are given a Digital Object Identifier (DOI), which allows them to be cited and tracked. The DOI remains unique to a given article in perpetuity. More information about DOIs can be found online at http://www.doi.org/faq.html. Given that Accepted Articles are not considered to be final, please note that changes will be made to an article after Accepted Article online publication, which may lead to differences between this version and the Version of Record.

The Accepted Articles service has been designed to ensure the earliest possible circulation of research papers after acceptance.

Accepted articles will be indexed by PubMed; Therefore the submitting author must carefully check the names and affiliations of all authors provided in the cover page of the manuscript, as it will not be possible to alter these once a paper is made available online in Accepted Article format. Subsequently the final copyedited and proofed articles will appear either as Early View articles in a matter of weeks or in an issue on Wiley Online Library; the link to the article in PubMed will automatically be updated.

……

更多详情:

https://analyticalsciencejournals.onlinelibrary.wiley.com/hub/journal/19427611/homepage/forauthors.html#enged


我来写点评
地址:
邮编:
电话:
微信公众号:
官网邮箱:
网址:
·相关杂志
·历史浏览
加入我们

公众号

助教

友情链接: 知网 万方 维普 龙源 新闻出版总署 国家社会科学基金 国家自然科学基金 中州期刊联盟
学术进修课堂 河南立孚教育科技有限公司版权所有   COPYRIGHT@2009-2025   豫ICP备 2024047992号